Pharmacy |
| ||
|
Panlipase Creon |
|
| ||
Home » Prescription Drugs 12 » Panlipase Creon This medication contains digestive enzymes to help break down and digest fats starch and proteins in food. It is used in conditions where the pancreas cannot make or does not release enough digestive enzymes into the small intestines to digest the food (e.g. chronic pancreatitis cystic fibrosis cancer of the pancreas post-pancreatectomy post-gastrointestinal bypass surgery). Buy Panlipase Creon and other Prescription Drugs 12 products online at Medstore. Buy Online at Medstore - Click Here!
About Panlipase Creon: Product Type: Prescription Drugs 12 Panlipase (Creon Generic Pancrelipase) Panlipase (Creon Generic Pancrelipase) Creon Generic Pancrelipase 10000+37500+3320IU 50 Capsules 10000+37500+3320IU 100(2 x 50) Capsules 10000+37500+3320IU 200(4 x 50) Capsules 10mg 50 Capsules 10mg 100(2 x 50 Capsules) 10mg 200(4 x 50 Capsules) Creon Generic Pancrelipase Panlipase
View more Prescription Drugs 12 Pharmacy: Dozens of patents for name-brand drugs are due to expire within the next 14 months, and generic drugs will replace some of the most popular and widely advertised drugs used today. For millions of people worldwide, this means switching from familiar brands like Lipitor to generic equivalents. How will this affect drug companies, and what will be the impact on people who depend on expensive prescription medication? Here, a brief guide: Which drugs are scheduled to go generic? Some real blockbusters. "In the next two years, six of the 10 top-selling drugs will lose their patents," says Chris Woolston in the Los Angeles Times. Lipitor, the world's best-selling drug, which is used to lower cholesterol, will be available as a generic in November of this year. Another best-seller, the blood thinner Plavix, will lose its patent in May 2012. Other well-known drugs with expiring patents include the arthritis treatment Enbrel, the anti-psychotic Zyprexa, as well as drugs for bipolar disorder, HIV, high cholesterol, and other conditions.
| ||
